NASDAQ
Corbus Pharmaceuticals Holdings, Inc. (CRBP) has a free cash flow growth of -60.58% as of Friday, May 29, 2026. This represents a 412.64% decrease compared to its 12-month average of -11.82%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.